-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Medpace Hldgs, Lowers Price Target to $500

Benzinga·02/11/2026 14:18:39
Listen to the news
Barclays analyst Luke Sergott maintains Medpace Hldgs (NASDAQ:MEDP) with a Underweight and lowers the price target from $525 to $500.